Danny Nguyen

1 month ago | politico.com | Danny Nguyen

AI TO THE RESCUE? With health systems stretched by staff shortages and rising chronic disease rates, some policymakers are pinning their hopes on artificial intelligence, our POLITICO colleagues in Europe report. The emerging technology “has the potential to transform the health care sector,” said Fulvia Raffaelli, head of digital health at DG SANTE, a branch of the European Commission responsible for EU public health and food safety policy, during a forum on the topic Wednesday.

1 month ago | politico.com | Danny Nguyen |Ben Johansen |Sophia Cai |Irie Sentner

Welcome to POLITICO’s West Wing Playbook: Remaking Government, your guide to Donald Trump’s unprecedented overhaul of the federal government — the key decisions, the critical characters and the power dynamics that are upending Washington and beyond. | Subscribe | | | Federal workers have gotten used to feeling the administration’s hammer. But now it is trying another tactic: bonuses.

1 month ago | politico.com | Danny Nguyen

Imagine if artificial intelligence could recognize signs of dementia in a person years before the condition fully emerges. How might early treatment impact the disease’s course? Could early treatment do away with the condition altogether? For decades, clinicians have focused primarily on treating the condition’s symptoms after they manifest. But new research by Yong Chen, who received an $8 million award from the National Institutes of Mental Health, could flip that on its head.

1 month ago | politico.com | Shawn Zeller |Danny Nguyen

A bipartisan group of Senate and House members has coalesced around proposed legislation to boost patent protections, our Anthony Adragna reports. Set to gain: inventors of medical diagnostics, biotechnology, personalized medicine and artificial intelligence. They’d gain more certainty that their inventions are patentable. Thom Tillis (R-N.C.) and Chris Coons (D-Del.) are the chief sponsors of the Patent Eligibility Restoration Act in the Senate.

1 month ago | politico.com | Danny Nguyen |Erin Schumaker

Pharma and biotech companies looking for consistency and predictability in an evolving health-artificial intelligence regulatory pipeline might find it at the Food and Drug Administration — even as the Trump administration shakes up the government, said attorneys at a health policy summit. Hogan Lovells, a prominent law and lobbying firm, hosted the event earlier this week in Washington.